Equities

Klotho Neuroscience Inc

KLTO:NMQ

Klotho Neuroscience Inc

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)0.859
  • Today's Change0.039 / 4.76%
  • Shares traded195.58k
  • 1 Year change-91.94%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Klotho Neuroscience, Inc., formerly ANEW Medical, Inc., is a specialty pharmaceutical company. The Company specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The Company focuses on central nervous systems (CNS) diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease (AD), dementia symptoms and neuromuscular diseases. It has exclusive worldwide rights to develop and commercialize product platforms based on its proprietary isoform transcribed from the human Klotho gene referred to as secreted Klotho or s-KL. This s-KL protein or gene therapy has been recognized for its potential to mitigate age-related pathologies such as ALS, Alzheimer's and Parkinson's Disease. Its lead gene therapy product candidates are AMI-101 (AAV9-CMV-sKL) (Alzheimer's disease), and AMI-202 (AAVmyo-Des-sKL) gene therapy product for treatment and prevention of Lou Gehrig's disease.

  • Revenue in USD (TTM)0.00
  • Net income in USD-744.61k
  • Incorporated2021
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Neon Bloom Inc741.11k-1.36m10.59m8.00------14.29-8.33-8.334.49-11.161.0913.9671.7192,638.75-200.77-------67.49---183.47--0.0542-11.93-----50.99---561.49------
Bimini Capital Management Inc17.44m-5.33m11.08m9.00--1.37--0.6353-0.5315-0.53151.740.80120.1563--48.901,937,262.00-4.78-1.94-13.50-5.4960.9264.24-30.60-32.95----0.9318--301.1320.5479.91------
Chase Packaging Corp0.00190.58k11.63m--61.2435.85----0.00310.00310.000.00520.00------51.60-105.6151.87-106.28------------0.00-------621.11------
BKF Capital Group Inc11.30m-15.00k11.69m3.00--1.61177.191.04-0.0257-0.025719.3712.441.022.6812.25--0.19775.050.27716.0831.13--0.194714.65---0.14870.00--253.62---79.84------
Santech Holdings Ltd - ADR261.97m-142.55m12.21m2.91k------0.0466-5.11-5.119.04--1.13--4.7790,178.05-62.1210.85-156.5220.5394.41---55.178.81----0.000.007.7112.68-44.9425.28-6.06--
Klotho Neuroscience Inc0.00-744.61k13.00m-----------0.0255-0.02550.00-0.0990.00-------2.46---2.56--------------1.66------9.14------
CaliberCos Inc72.10m-14.17m13.53m99.00------0.1877-0.6588-0.65883.36-0.21520.2751--1.58728,282.80-10.26---19.32-------37.29-----5.570.4767--8.32---724.50------
IMD Companies Inc439.50k-330.55k13.96m3.00------31.76-0.0053-0.00530.0049-0.00210.430331.325.58146,500.00-32.36-41.61-43.47-58.1633.5249.68-75.21-89.491.05--1.48--26.65---47.11------
Renn Fund Inc309.88k1.10m14.45m0.0013.140.9195--46.640.15680.15680.04422.240.02--12.97--7.101.927.211.9374.8550.50354.89173.97----0.00--27.9235.0379.10------
Xsovt Brands Inc-230.00-2.27m14.75m0.00---------0.1416-0.1416-0.00002-0.0753-0.0013-------1,249.08--------100.00---37,918.24---10.04-----66.13---1.90------
Sos Ltd - ADR92.42m-3.65m14.82m181.001.540.0239--0.16040.48710.48710.516831.330.19691.9857.03510,585.60-1.37-19.41-1.54-23.1715.35---6.95-44.85----0.00---64.464.1498.41------
9F Inc - ADR58.53m-19.88m14.83m276.00--0.0297--0.2535-1.69-1.694.9742.380.0988--6.34212,049.40-3.82-17.48-4.43-20.9672.0973.54-38.69-71.30----0.00---26.53-40.5576.43---34.75--
Safeguard Scientifics Inc0.00-9.83m14.90m33.00--0.7414-----0.6063-0.60630.001.200.00-------32.475.63-34.696.10-----------0.91930.00------31.09------
Peregrine Industries Inc21.75k-223.64k15.53m2.00--15.56--714.23-0.0009-0.00090.000090.0040.01760.01692.4210,875.00-18.08-25.16-18.34-26.0553.38---1,028.23-305.1940.62--0.1122---3.13---295.28------
CSLM Acquisition Corp0.001.49m15.63m3.0087.912.4527.40--0.12960.12960.004.650.00------1.17--1.26--------------0.0459------124.90------
Data as of Sep 20 2024. Currency figures normalised to Klotho Neuroscience Inc's reporting currency: US Dollar USD

Institutional shareholders

13.14%Per cent of shares held by top holders
HolderShares% Held
W.R. Berkley Corp. (Investment Portfolio)as of 31 Mar 2024188.79k3.66%
Meteora Capital LLCas of 31 Mar 2024150.00k2.90%
RiverNorth Capital Management LLCas of 31 Mar 2024111.75k2.16%
Clear Street LLCas of 31 Mar 2024107.73k2.09%
Karpus Management, Inc.as of 31 Mar 202469.95k1.35%
Fir Tree Capital Management LPas of 31 Mar 202450.30k0.97%
Tower Research Capital LLCas of 31 Mar 2024241.000.01%
UBS Securities LLCas of 31 Mar 202476.000.00%
North Star Investment Management Corp.as of 30 Jun 202420.000.00%
Dakota Wealth LLCas of 30 Jun 20240.000.00%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.